Trial intelligence / Profile preview

Pre-emptive Ibuprofen for Pain in Children with MIH

NCT03953729Phase 1Unknown

Sponsor
Universidade de São Paulo
Start
Apr 2019
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, triple-blind trial in pain comparing Group 1: Ibuprofeno with Group 2: Placebo (2 arms). Primary endpoint: Visual Pain Scale at 24 hours. Status: unknown.

02

Drugs

ibuprofen
03

Conditions

pain

Beyond the preview

Go deeper on NCT03953729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03953729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call